Platform
Features
0 followers
Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye.
Industries
Headquarters
Stage
Employees
Links
Thomas Cavanagh
11 members
3 members
2 members
Immunocore
1 follower
Cellares
2 followers
GRAIL
27 followers
argenx
10 followers
Isometric
FXSwede
36 followers
Adani Group
17 followers
Zealand
4 followers
AbbVie
149 followers
Incyte
14 followers
Tessera Therapeutics
Discover companies